Page last updated: 2024-08-17

nad and a-Synucleinopathies

nad has been researched along with a-Synucleinopathies in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's1 (100.00)2.80

Authors

AuthorsStudies
Facey, PD; Hirth, F; Kocinaj, A; Parsons, AE; Parsons, RB; Prendergast, SA; Ruiz Pulido, G1

Other Studies

1 other study(ies) available for nad and a-Synucleinopathies

ArticleYear
Alpha-synucleinopathy reduces NMNAT3 protein levels and neurite formation that can be rescued by targeting the NAD+ pathway.
    Human molecular genetics, 2022, 08-25, Volume: 31, Issue:17

    Topics: alpha-Synuclein; Dopaminergic Neurons; Humans; NAD; Neurites; Neuroblastoma; Nicotinamide-Nucleotide Adenylyltransferase; Parkinson Disease; Synucleinopathies

2022